Tabay, Krizza Jean E.
HRN: 21-98-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2023
CEFUROXIME 500MG (TAB)
06/05/2023
06/06/2023
PO
500mg
Bid
S/p Thyroid Lobectomy Left
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes